Literature DB >> 14982806

Inhibitors of antibiotic efflux in resistant Enterobacter aerogenes and Klebsiella pneumoniae strains.

Jacqueline Chevalier1, Jérôme Bredin, Abdallah Mahamoud, Monique Malléa, Jacques Barbe, Jean-Marie Pagès.   

Abstract

In Enterobacter aerogenes and Klebsiella pneumoniae, efflux provides efficient extrusion of antibiotics and contributes to the multidrug resistance phenotype. One of the alkoxyquinoline derivatives studied here, 2,8-dimethyl-4-(2'-pyrrolidinoethyl)-oxyquinoline, restores noticeable drug susceptibility to resistant clinical strains. Analyses of energy-dependent chloramphenicol efflux indicate that this compound inhibits the efflux pump mechanism and improves the activity of structurally unrelated antibiotics on multidrug-resistant E. aerogenes and K. pneumoniae isolates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982806      PMCID: PMC353160          DOI: 10.1128/AAC.48.3.1043-1046.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

Review 1.  The mar regulon: multiple resistance to antibiotics and other toxic chemicals.

Authors:  M N Alekshun; S B Levy
Journal:  Trends Microbiol       Date:  1999-10       Impact factor: 17.079

Review 2.  In search of natural substrates and inhibitors of MDR pumps.

Authors:  K Lewis
Journal:  J Mol Microbiol Biotechnol       Date:  2001-04

3.  Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export.

Authors:  V Koronakis; A Sharff; E Koronakis; B Luisi; C Hughes
Journal:  Nature       Date:  2000-06-22       Impact factor: 49.962

Review 4.  Phylogeny of multidrug transporters.

Authors:  M H Saier; I T Paulsen
Journal:  Semin Cell Dev Biol       Date:  2001-06       Impact factor: 7.727

Review 5.  Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria.

Authors:  H Nikaido
Journal:  Semin Cell Dev Biol       Date:  2001-06       Impact factor: 7.727

6.  National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998.

Authors:  Y De Gheldre; M J Struelens; Y Glupczynski; P De Mol; N Maes; C Nonhoff; H Chetoui; C Sion; O Ronveaux; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

7.  Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae.

Authors:  J Chevalier; J M Pagès; A Eyraud; M Malléa
Journal:  Biochem Biophys Res Commun       Date:  2000-08-02       Impact factor: 3.575

8.  Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.

Authors:  O Lomovskaya; M S Warren; A Lee; J Galazzo; R Fronko; M Lee; J Blais; D Cho; S Chamberland; T Renau; R Leger; S Hecker; W Watkins; K Hoshino; H Ishida; V J Lee
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

9.  Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability.

Authors:  C Bornet; A Davin-Regli; C Bosi; J M Pages; C Bollet
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

10.  Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes.

Authors:  Monique Mallea; Jacqueline Chevalier; Charleric Bornet; Annie Eyraud; Anne Davin-Regli; Claude Bollet; Jean-Marie Pages
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

View more
  21 in total

1.  Inactivation of efflux pumps abolishes bacterial biofilm formation.

Authors:  Malin Kvist; Viktoria Hancock; Per Klemm
Journal:  Appl Environ Microbiol       Date:  2008-10-03       Impact factor: 4.792

Review 2.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 3.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 4.  Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.

Authors:  Hiroshi Nikaido; Jean-Marie Pagès
Journal:  FEMS Microbiol Rev       Date:  2011-07-29       Impact factor: 16.408

5.  Influence of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori.

Authors:  Zhan Zhang; Zhi-Qiang Liu; Peng-Yuan Zheng; Fu-Ai Tang; Ping-Chang Yang
Journal:  World J Gastroenterol       Date:  2010-03-14       Impact factor: 5.742

Review 6.  Microbial efflux pump inhibition: tactics and strategies.

Authors:  George P Tegos; Mark Haynes; J Jacob Strouse; Mohiuddin Md T Khan; Cristian G Bologa; Tudor I Oprea; Larry A Sklar
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

7.  The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli.

Authors:  Renaud Chollet; Jacqueline Chevalier; André Bryskier; Jean-Marie Pagès
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Elucidating the regulon of multidrug resistance regulator RarA in Klebsiella pneumoniae.

Authors:  Shyamasree De Majumdar; Mark Veleba; Sarah Finn; Séamus Fanning; Thamarai Schneiders
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

9.  Efflux Pump Overexpression Profiling in Acinetobacter baumannii and Study of New 1-(1-Naphthylmethyl)-Piperazine Analogs as Potential Efflux Inhibitors.

Authors:  Morgane Choquet; Elodie Lohou; Etienne Pair; Pascal Sonnet; Catherine Mullié
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

10.  Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation.

Authors:  Christina Kourtesi; Anthony R Ball; Ying-Ying Huang; Sanjay M Jachak; D Mariano A Vera; Proma Khondkar; Simon Gibbons; Michael R Hamblin; George P Tegos
Journal:  Open Microbiol J       Date:  2013-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.